|
|
Article: GRAZAX(R) Approved in Europe - Good News for the Millions of Grass Allergy Sufferers in Europe.
- Article from:
- PR Newswire Europe
- Article date:
- September 25, 2006
CopyrightCOPYRIGHT 2006 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
HEyRSHOLM, Denmark, September 25 /PRNewswire/ --
- Authorities in 27 European Countries Have Now Approved ALK-Abello's Tablet-Based Vaccine Against Grass Pollen Allergy, GRAZAX(R)- the First Allergy Tablet to Address the Underlying Cause Of the Disease. ALK-Abello Expects to Launch the Innovative and Convenient Treatment on the First European Markets by the End of 2006, Ahead of the 2007 Pollen Season.
ALK-Abello today completed the European Mutual Recognition Procedure for GRAZAX(R), the company's tablet-based vaccine against grass pollen allergy, and authorities in 27 European countries have now approved the tablet treatment[1].
"We are very ...